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Snake fungal disease in Lake Eerie water snakes and
its affect on attitude and behavior during treatment
Kelcie Fredrickson
Abstract
Snake fungal disease (SFD) is caused by the fungus
Ophidiomyces ophiodiicola. Infection occurs when the outer skin is
breached, and the organism enters the epidermis. The epidermis
becomes necrotic and produces a yellow/brown crust. When the crust
breaks off, ulcerations/lesions are formed along the snake’s body,
head and tail. It has been found that SFD can be treated with a
terbinafine nebulization treatment. Ellen Haynes, a PhD student,
created a study in which 26 Lake Eerie water snakes are separated
into treatment and control groups to determine the effectiveness of
the nebulization treatment. Through daily observations, this research
aimed to compare the snakes in the treatment and control groups by
categorizing them by attitude and behavior. The 12 snakes in the
treatment group were bright-alert-responsive (BAR) 5% less than the
10 snakes in the control group. The treatment snakes were only BAR
9 of 47 days compared to the control snakes that were BAR 12 of 47
days. This shows that the snakes that are lethargic in nature are more
likely to survive.

Introduction
The earliest case of snake fungal disease, or SFD, was discovered
in 2000 in southern Illinois and was initially found in rattlesnakes.
For the past 18 years, it has been a growing concern in reptile
populations due to the widespread morbidity and mortality rates
(Allender et al. 2015). Since then, it has been discovered in six
different snake families which account for over 30 different species
(Hileman et al. 2018). SFD is caused by the fungus Ophidiomyces
ophiodiicola. This fungus recently split from a complex of fungi
called Chysosoporium anamoph of nannizziopsis vriesil (Lorch et al.
2016). SFD occurs when the snake’s outer skin is breached which
allows this fungus to enter into the epidermis. Once the fungus is in
the epidermis, it only takes days for the infection to worsen. The
epidermis becomes necrotic and thickened which produces a
yellow/brown crust common to SFD. This crust then breaks off which
creates ulcerations along the snake’s body, head and tail. Once
infected with SFD, snakes begin to exhibit unusual behaviors due to
an increase in body temperature (Allender et al. 2016).
It has been previously discovered that SFD can be treated using a
Terbinafine nebulization treatment. Terbinafine is an antifungal
medication that works by stopping the growth of the targeted fungus.
In humans, Terbinafine is taken orally once daily but due to the
difficulty of orally feeding medication to snakes, the nebulization
method is preferred. To do this, the snakes are transferred to a new
tank designed to fill with the Terbinafine fumes to treat their fungal
diseases (Kane et al. 2017). Ellen Haynes, one of the Ph.D. students
attending the University of Illinois, had created a study which
involved 30 Lake Eerie water snakes (LEWS) and focuses on SFD
and the nebulization treatment. She tested each snake to determine
their level of infection and, depending on this level, matched them
with a snake that has the same level of infection. To determine the
level of infection, TaqMan polymerase chain reactions (qPCR) are
run. The pair of snakes is then divided into a control and treatment
groups and is randomly selected to be placed in 1 of 4 rounds to be
treated daily. The treatment group is treated using the Terbinafine
nebulization method. The control group is also placed in a tank to be
nebulized, however, this group is treated with a saline solution. Both
groups are placed in the nebulization tank and exposed to fumes for
30 minutes. This allows the snakes to go through the same situations
and stresses, while allowing sufficient comparisons to occur. Out of
26 total snakes, 13 snakes were undergoing treatment and 13 were in
the control group.
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Conclusion

During treatment, the snakes being treated for SFD will not
likely be as severe as their control counterparts, so the focus of this
research is how SFD affects the snake’s overall attitude and
behavior. The research will be based on the comparison of snakes
undergoing treatment versus the control groups. Snakes are
classified into two groups during their treatments based on natural
behaviors and reactions to human interaction. They can be either:
bright-alert-responsive and quiet-alert-responsive. Since SFD
causes an increase in body temperature, it can be assumed that
their activity levels and natural behaviors will differ depending on
whether they are being treated or not. It can be hypothesized that
the snakes in the control group will be classified as quiet-alertresponsive more that the snakes in the control group because they
will remain hidden in an attempt to cool their body temperature.

Materials & Methods
Once the snakes are placed into groups and rounds, observations
will begin to be taken daily. Each day the snakes will be observed
and placed in a category of bright-alert-responsive (BAR) or quietalert-responsive (QAR). To be classified as BAR, the snake be out in
the open and/or reacting to humans being in the room/being handled.
To be classified as QAR, the snake will be hiding and/or
unresponsive to humans being in the room/being handled. These
daily observations will continue for three weeks. This data will
include measurements taken for a week prior to the start of treatment
and two weeks into treatment.

Figure 2: SFD lesions on vipers. A) Active region under the ocular
region of a cottonmouth. B) Crusts present under the scales of a
massasauga. C & D) Lesions resulting from a more advanced infection
present on two massasaugas. Arrows on the images show the location of
the lesion (Allender et al. 2015).

Discussion
The results show that the snakes that are suffering without
treatment are on average more active and alert than those that are
being treated. The snakes in the control group were considered BAR
5% more than the treatment snakes. The snakes acting lethargic are
less likely to be suffering, according to the results. Although being
active and alert appears healthy in most species, in snakes infected
with SFD, this may be a sign of severe illness. This data does not
support the hypothesis because it shows that being treated for the fungal
infection, makes the snake more QAR. During future data collection

Figure 1: Nebulization treatment tank. The image above shows the
nebulization tank during a treatment of a snake with SFD. The fumes
will enter the tank through the tube and will be trapped inside to
ensure max exposure during the 30-minute treatment period (Yates
2017).

Results
The snakes being treated with terbinafine for SFD were BAR 110
days out of a combined total of 560 days for the 12 snakes. These
snakes were BAR only nine days out of 47 during their treatment on
average. The snakes undergoing a control treatment of saline were
BAR 115 days out of a combined total of 468 for the 10 snakes.
These snakes were BAR 12 days out of 47. The control snakes were
considered bright-alert-responsive up to 5% more than the treatment
snakes.

and treatments, veterinarians and researches will be sure to focus on
signs of suffering in the snakes that are more active than those that
aren’t.
During this experiment, complications occurred which may have
altered the outcome of the study. One complication is in regard to the
number of days each snake was observed. Although, they underwent
treatment for the same amount of time, the overall number of days
they were observed varies. This makes the average data seem more as
an estimation than an exact value. For example, more of the snakes
were observed for 47 days than 45 or 46 so the averages round up.
Another complication that may have occurred is the number of
people doing the observations. Since, multiple people did the daily
observations, the criteria for each category may have been different.
During the experiment, three snakes died, and one had to be
euthanized as a result of the severity of their infections. This lowered
the sample size from 26 snakes to 22 with 12 in the treatment group
and only 10 in the control group. This alteration of sample size may
have altered the overall results, but enough data has been collected
for adequate comparison of the two groups.
The site may use these complications and setbacks to alter their
observation and recording method. Since the observations may have
varied so much, they may add a chart that describes each state, or
they may ask for a single person doing the observing to maintain
consistency. Overall the setbacks and gains from this experiment will
only benefit the lab in the future by forming a more advanced way to
record observations for each snake.

SFD has become a growing concern in the past 18 years because
the current threat to snakes is unknown. This fungal infection causes
significant morbidity and mortality among wild snake populations. In
recent years, research has been done on ways to treat SFD and these
studies have shown that a terbinafine nebulization treatment is
effective. Terbinafine is an antifungal medication that can be
nebulized to treat reptiles. Ellen Haynes proposed a research project
to determine the effectiveness of the terbinafine treatment by
comparing the treatment group to a control group containing snakes
with the same level of infection. During her research, daily
observations were taken of the snakes to determine if they were BAR
or QAR. This data was then compared between the control and
treatment group to see the affect SFD has on the snake’s attitude and
behavior. It was discovered that the snakes in the treatment group
were BAR 5% more than the snakes in the treatment group. This
disproves the hypothesis but provides valuable data for future studies.
This shows that the snake that are more lethargic in nature are
healthier and more likely to survive on average. This research can be
applied to future studies by turning the researchers attention from the
QAR snakes to the BAR snakes for disease severity.
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